Gland Pharma Limited (NSEI: GLAND)
Health Care · Pharmaceuticals · IN
Rs2,874.40
-1.47% today · +47.3% 1Y
Gland Pharma Limited (NSEI: GLAND) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.92B and employs 4,332 people.
Over the last twelve months the share price has gained 47.3%, trading between 1.57K and 3.04K.
Tweenvest scores Gland Pharma Limited across four factors: quality 77/100, value 25/100, growth 65/100, dividend 51/100. Its strongest factor is quality.
GLAND price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.92B
- Revenue (TTM)
- $711.28M
- P/E
- 42.01
- EPS
- 68.41
- Dividend yield
- 0.70%
- Beta (5Y)
- 0.58
- 52-week high
- Rs3,042.00
- 52-week low
- Rs1,573.60
- Avg volume (3M)
- —
- Shares outstanding
- 164.97M
- Employees
- 4,332
- Next earnings
- —
About Gland Pharma Limited
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
- ISIN
- INE068V01023
- Founded
- 1978
- Listed since
- Nov 20, 2020
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.SZSE: 000999 | $6.00B | CN¥24.19 | +3.20% |
| Abbott India LimitedBSE: 500488 | $5.92B | Rs26,832.10 | -0.38% |
| Ipca Laboratories LimitedNSEI: IPCALAB | $5.12B | Rs1,943.20 | -1.40% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd.SZSE: 002294 | $5.07B | CN¥30.66 | +1.46% |
| GlaxoSmithKline Pharmaceuticals LimitedBSE: 500660 | $4.88B | Rs2,774.50 | -1.50% |
| Veradermics, IncorporatedNYSE: MANE | $4.88B | $126.63 | +8.45% |
| Beijing Tongrentang Co., LtdSHSE: 600085 | $4.85B | CN¥23.74 | +1.71% |
| Hanmi Pharm. Co., Ltd.KOSE: A128940 | $4.77B | ₩506,000.00 | -2.69% |
Figures last refreshed Oct 4, 2026.